查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1698263

智慧药丸市场机会、成长动力、产业趋势分析及 2025-2034 年预测

Smart Pills Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 225 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球智慧药丸市场规模达到 12 亿美元，预计 2025 年至 2034 年期间复合年增长率将达到惊人的 11.6%。胃肠道疾病盛行率的上升以及对非侵入性诊断解决方案的需求的增加是推动这一增长的主要因素。随着医疗保健产业向微创技术转变，智慧药丸正在彻底改变诊断和治疗方法。这些可摄取的医疗设备配备感测器、微晶片和无线通讯功能，可实现即时患者监测、精确药物传输和增强疾病追踪。个人化医疗和远距医疗解决方案的需求日益增长，进一步加速了市场采用智慧药丸，因为智慧药丸提供了无缝的诊断和治疗组合，同时最大限度地减少了患者的不适。

智慧药丸市场 - IMG1

此外，慢性病负担的增加、全球人口老化以及医疗保健支出的增加也促进了市场的扩张。政府支持数位医疗以及人工智慧 (AI) 和物联网 (IoT) 技术进步的倡议正在促进市场的快速发展。人工智慧药丸正在提高资料处理效率，实现更快、更准确的诊断，同时优化治疗方案。同时，物联网整合可以实现持续的病患监控，减少医院就诊次数并改善整体医疗管理。随着医疗保健提供者和患者越来越认识到智慧药丸的好处，未来十年市场将呈指数级增长。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 12亿美元
预测值 34亿美元
复合年增长率 11.6％

市场根据组件细分为产品和患者监测软体。 2024 年，该产品部门的收入为 7.259 亿美元，这主要得益于嵌入微晶片和感测器的智慧胶囊的日益普及。这些胶囊在监测胃肠道健康、确保药物依从性和追踪病情进展方面发挥着至关重要的作用。透过提供即时资料，智慧胶囊可以实现精确的药物管理，同时无需传统的侵入性诊断程序。这些解决方案的易用性和非侵入性使其成为医疗诊断和治疗应用的首选。

市场进一步依目标区域分类，应用范围涵盖胃、小肠、大肠和食道。 2024 年，胃病领域占据了 44.1% 的市场份额，这主要是由于胃病患病率不断上升以及对即时、非侵入性诊断工具的需求增加。专为胃部应用而设计的智慧药丸可提高诊断准确性和治疗效果，解决多种胃肠道疾病。胃病发病率的不断上升刺激了对这些创新解决方案的需求，使胃部成为市场的主导部分。

北美仍然是智慧药丸的主要市场，到 2024 年将达到 4.555 亿美元，预计未来几年的复合年增长率为 11.3%。该地区受益于完善的医疗保健基础设施、早期采用的先进医疗技术以及日益增长的易患慢性疾病的老年人口。胃肠道疾病的增多，加上可摄取感测器技术的不断进步，正在推动市场扩张。专注于医疗技术研究和创新的关键产业参与者正在进一步推动市场成长，巩固北美在全球智慧药丸产业的地位。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

  • 产业生态系统分析
  • 产业衝击力
    • 成长动力
      • 胃肠道疾病盛行率不断上升
      • 智慧药丸技术的不断改进
      • 非侵入性诊断工具的需求不断增长
    • 产业陷阱与挑战
      • 严格的监管要求
      • 设备成本高
  • 成长潜力分析
  • 技术格局
  • 监管格局
  • 未来市场趋势
  • 波特的分析
  • PESTEL 分析

第四章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 策略仪表板

第五章：市场估计与预测：按组成部分，2021 年至 2034 年

  • 主要趋势
  • 产品
    • 胶囊
    • 其他产品
  • 病人监护软体

第六章：市场估计与预测：按目标区域，2021 年至 2034 年

  • 主要趋势
  • 胃
  • 小肠
  • 大肠
  • 食道

第七章：市场估计与预测：按应用，2021 年至 2034 年

  • 主要趋势
  • 胶囊内视镜
  • 靶向药物输送
  • 生命征象监测

第八章：市场估计与预测：依最终用途，2021 年至 2034 年

  • 主要趋势
  • 医院
  • 诊断中心
  • 其他最终用途

第九章：市场估计与预测：按地区，2021 年至 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第十章：公司简介

  • ANX Robotica
  • Bodycap
  • CapsoVision
  • Check-Cap
  • etectRx
  • Intromedic
  • Medtronic
  • Otsuka Holdings
  • Olympus Corporation
  • RF Co
简介目录
Product Code: 13214

The Global Smart Pills Market reached USD 1.2 billion in 2024 and projected to register an impressive CAGR of 11.6% from 2025 to 2034. The rising prevalence of gastrointestinal disorders and the increasing demand for non-invasive diagnostic solutions are major factors fueling this growth. As the healthcare industry shifts toward minimally invasive technologies, smart pills are revolutionizing diagnostics and treatment approaches. These ingestible medical devices, equipped with sensors, microchips, and wireless communication capabilities, enable real-time patient monitoring, precise drug delivery, and enhanced disease tracking. The growing need for personalized medicine and remote healthcare solutions is further accelerating market adoption, as smart pills offer a seamless blend of diagnostics and treatment with minimal discomfort to patients.

Smart Pills Market - IMG1

Additionally, the rising burden of chronic diseases, an aging global population, and increased healthcare spending are contributing to the market's expansion. Government initiatives supporting digital healthcare and technological advancements in artificial intelligence (AI) and the Internet of Things (IoT) are reinforcing the market's rapid evolution. AI-powered smart pills are enhancing data processing efficiency, enabling faster and more accurate diagnoses while optimizing treatment plans. Meanwhile, IoT integration allows continuous patient monitoring, reducing hospital visits and improving overall healthcare management. With healthcare providers and patients increasingly recognizing the benefits of smart pills, the market is poised for exponential growth over the next decade.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$1.2 Billion
Forecast Value$3.4 Billion
CAGR11.6%

The market is segmented based on components into products and patient monitoring software. In 2024, the product segment generated USD 725.9 million, largely driven by the increasing adoption of smart capsules embedded with microchips and sensors. These capsules play a crucial role in monitoring gastrointestinal health, ensuring medication adherence, and tracking disease progression. By delivering real-time data, smart capsules enable precise drug administration while eliminating the need for traditional invasive diagnostic procedures. The ease of use and non-invasive nature of these solutions are making them a preferred choice for medical diagnostics and therapeutic applications.

The market is further classified by target area, with applications spanning the stomach, small intestine, large intestine, and esophagus. The stomach segment accounted for 44.1% of the market share in 2024, largely due to the increasing prevalence of stomach-related disorders and the demand for real-time, non-invasive diagnostic tools. Smart pills designed for stomach applications offer enhanced diagnostic accuracy and improved treatment efficacy, addressing a broad range of gastrointestinal conditions. The growing incidence of gastric diseases is fueling demand for these innovative solutions, making the stomach a dominant segment within the market.

North America remains a leading market for smart pills, reaching USD 455.5 million in 2024 and expected to grow at a CAGR of 11.3% in the coming years. The region benefits from a well-established healthcare infrastructure, early adoption of advanced medical technologies, and a rising elderly population prone to chronic illnesses. The increasing number of gastrointestinal disorders, coupled with continuous technological advancements in ingestible sensors, is driving market expansion. Key industry players focused on research and innovation in medical technology are further propelling market growth, reinforcing North America's stronghold in the global smart pills industry.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of gastrointestinal disorders
      • 3.2.1.2 Continuous improvements in smart pill technology
      • 3.2.1.3 Growing demand for non-invasive diagnostic tools
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Stringent regulatory requirements
      • 3.2.2.2 High cost of devices
  • 3.3 Growth potential analysis
  • 3.4 Technology landscape
  • 3.5 Regulatory landscape
  • 3.6 Future market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Product
    • 5.2.1 Capsule
    • 5.2.2 Other products
  • 5.3 Patient monitoring software

Chapter 6 Market Estimates and Forecast, By Target Area, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Stomach
  • 6.3 Small intestine
  • 6.4 Large intestine
  • 6.5 Esophagus

Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Capsule endoscopy
  • 7.3 Targeted drug delivery
  • 7.4 Vital sign monitoring

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Diagnostic centers
  • 8.4 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 ANX Robotica
  • 10.2 Bodycap
  • 10.3 CapsoVision
  • 10.4 Check-Cap
  • 10.5 etectRx
  • 10.6 Intromedic
  • 10.7 Medtronic
  • 10.8 Otsuka Holdings
  • 10.9 Olympus Corporation
  • 10.10 RF Co